These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 18633217

  • 1. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
    Hodozuka A, Hayashi Y, Annei R, Hiroshima S, Saito M, Orimoto R, Sato M, Tanaka T.
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
    [Abstract] [Full Text] [Related]

  • 2. [Clinical application of FdUrd to meningeal dissemination of malignant tumors].
    Nakagawa H, Yamada M, Maeda N, Iwatsuki K, Tsuzuki T, Hirayama A, Yamamoto H, Ikenaka K.
    No Shinkei Geka; 1998 Nov; 26(11):969-77. PubMed ID: 9834491
    [Abstract] [Full Text] [Related]

  • 3. [Study of meningeal carcinomatosis: diagnosis and treatment].
    Nakagawa H, Murasawa A, Nakajima S, Nakajima Y, Izumoto S, Kubo S, Hayakawa T.
    No Shinkei Geka; 1992 Jan; 20(1):31-7. PubMed ID: 1738424
    [Abstract] [Full Text] [Related]

  • 4. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
    Glantz MJ, Jaeckle KA, Chamberlain MC, Phuphanich S, Recht L, Swinnen LJ, Maria B, LaFollette S, Schumann GB, Cole BF, Howell SB.
    Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
    [Abstract] [Full Text] [Related]

  • 5. [Ventriculo-lumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal dissemination of malignant disease].
    Nakagawa H, Fujita T, Kubo S, Izumoto S, Nakajima Y, Tsuruzono K.
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1173-9. PubMed ID: 2053775
    [Abstract] [Full Text] [Related]

  • 6. [Diffuse metastatic leptomeningeal carcinomatosis (DMLC)].
    Ishikura A, Hunaki N.
    Gan No Rinsho; 1987 Jul; 33(8):881-4. PubMed ID: 3613110
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
    Kooistra KL, Rodriguez M, Powis G.
    Cancer Res; 1989 Feb 15; 49(4):977-82. PubMed ID: 2912564
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR.
    Rebischung C, Hoffmann D, Stefani L, Desruet MD, Wang K, Adelstein SJ, Artignan X, Vincent F, Gauchez AS, Zhang H, Fagret D, Vuillez J, Kassis AI, Balosso J.
    Int J Radiat Biol; 2008 Dec 15; 84(12):1123-9. PubMed ID: 19061137
    [Abstract] [Full Text] [Related]

  • 11. Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004).
    Gururangan S, Petros WP, Poussaint TY, Hancock ML, Phillips PC, Friedman HS, Bomgaars L, Blaney SM, Kun LE, Boyett JM.
    Clin Cancer Res; 2006 Mar 01; 12(5):1540-6. PubMed ID: 16533779
    [Abstract] [Full Text] [Related]

  • 12. Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine.
    Jaeckle KA, Phuphanich S, Bent MJ, Aiken R, Batchelor T, Campbell T, Fulton D, Gilbert M, Heros D, Rogers L, O'Day SJ, Akerley W, Allen J, Baidas S, Gertler SZ, Greenberg HS, LaFollette S, Lesser G, Mason W, Recht L, Wong E, Chamberlain MC, Cohn A, Glantz MJ, Gutheil JC, Maria B, Moots P, New P, Russell C, Shapiro W, Swinnen L, Howell SB.
    Br J Cancer; 2001 Jan 01; 84(2):157-63. PubMed ID: 11161370
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
    Orlando L, Curigliano G, Colleoni M, Fazio N, Nole F, Martinelli G, Cinieri S, Graffeo R, Peruzzotti G, Goldhirsch A.
    Anticancer Res; 2002 Jan 01; 22(5):3057-9. PubMed ID: 12530042
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride.
    Kochi M, Kuratsu J, Mihara Y, Takaki S, Seto H, Uemura S, Ushio Y.
    Neurosurgery; 1993 Nov 01; 33(5):817-23. PubMed ID: 8264878
    [Abstract] [Full Text] [Related]

  • 18. Current status of intrathecal chemotherapy for human meningeal neoplasms.
    Bleyer WA.
    Natl Cancer Inst Monogr; 1977 Dec 01; 46():171-8. PubMed ID: 580638
    [Abstract] [Full Text] [Related]

  • 19. [Intrathecal ACNU for the treatment of a meningeal gliomatosis model].
    Yoshida T, Shimizu K, Mogami H, Egawa T, Sakamoto Y.
    Gan To Kagaku Ryoho; 1987 Jan 01; 14(1):84-90. PubMed ID: 3467657
    [Abstract] [Full Text] [Related]

  • 20. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.
    Stemmler HJ, Mengele K, Schmitt M, Harbeck N, Laessig D, Herrmann KA, Schaffer P, Heinemann V.
    Anticancer Drugs; 2008 Sep 01; 19(8):832-6. PubMed ID: 18690096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.